March 29th 2022
Is prolonged grief disorder an important addition to the DSM-5-TR?
2022 Annual Psychiatric Times™ World CME Conference™ - Day Three
View More
2022 Annual Psychiatric Times™ World CME Conference™ - Day Two
View More
2022 Annual Psychiatric Times™ World CME Conference™ - Day One
View More
Recognizing Rett Syndrome Early to Improve Long-Term Management Outcomes
Register Now!
Shaping the Management of Multiple Sclerosis – The Potential for BTK Inhibitors in Clinical Practice
View More
Transforming Multiple Sclerosis Care – Clinical Updates on the Effects of BTK Inhibitors
10/13/2023
Register Now!
2023 Annual Psychiatric Times™ World CME Conference
View More
From Clinical Trials to Clinical Practice – Incorporating Screening and Assessment Strategies for the Early Diagnosis of Alzheimer Disease
View More
Taking Pompe Disease Management to the Next Level: Optimizing Clinical Assessments and Treatment Decision-Making
View More
Addressing Healthcare Inequities in Stroke Care: How Can We Play an Active Role in Improving Outcomes for All Patients?
View More
2022 4th Annual International Congress on the Future of Neurology
View More
Understanding Best Care Practices for Hemorrhagic Stroke – A Focus on the Role of DOAC Reversals
View More
Clinical Consultations™: Integrating Modern Antipsychotic Medications into the Management of Patients with Schizophrenia
View More
Collaborating Across the Continuum™ : Managing Relapsing MS – A Focus on the Utility of CD20-Targeted B-Cell Therapy
View More
Patient, Provider, and Caregiver Connection™: Challenges in Diagnosis and Management for Patients with ADHD During the COVID-19 Pandemic
View More
Expert Illustrations & Commentaries™: A Family Physicians’ Guide to Migraine Treatment – Emerging Therapies and Evolving Paradigms
View More
PER® Postgame™: MS Meeting Updates – Integrating the Latest Data to Optimize Care in the COVID-19 Era
View More
Medical Crossfire®: What Strategies Can the Care Team Implement to Optimize the Management of Pediatric Patients with NF1?
View More
Expert Illustrations & Commentaries™: Visualizing the Role of Antipsychotics in the Management of Schizophrenia: What is the Role of TAAR1?
View More
Patient, Provider, & Caregiver Connection: Individualizing Care in Multiple Sclerosis – Understanding Patient Challenges and the Role of Innovative Treatment
View More
FAQs in MS: Exploring Provocative Questions From MS Meeting Updates
View More
BURST CME™: Taking ALS Management to the Next Level
View More
The Expanding Role of Fluid Biomarkers in the Diagnosis and Management of Patients With Alzheimer Disease
View More
Expert Illustrations & Commentaries™: Targeting Immune Cells to Treat Multiple Sclerosis
View More
Improving Care for Patients with Motor Complications of Parkinson Disease: Role of Technology and Data
View More
Clinical Consultations™: Considerations for Customizing Care Plans for Patients with Parkinson Disease Psychosis
View More
Expert Illustrations & Commentaries™: Visualizing New Therapeutic Targets in Schizophrenia
View More
Advances In™ Schizophrenia: Expanding the Therapeutic Landscape
View More
Advances In Treating Migraine in Your OB/GYN Practice: Navigating Treatment Paradigms to Improve Patient Care
View More
Wonderful News: DSM-5 Finally Begins Its Belated And Necessary Retreat
May 5th 2012For the first time in its history, DSM-5 has shown some flexibility and capacity to correct itself. Hopefully, this is just the beginning of what will turn out to be a number of other necessary DSM-5 retreats.
Read More
DSM-5 in the Homestretch-1. Integrating the Coding Systems
March 8th 2012With DSM-5 scheduled for publication a little more than a year from now, we may safely assume that, barring unannounced surprises from, say, the APA Scientific Review Committee, what we will see on the DSM-5 Web site is what we will get. With that in mind it’s time to review what we will indeed get.
Read More
After Bereavement, Is It “Normal Grief” or Major Depression?
February 22nd 2012Much of the controversy on the relationship between grief and depression following recent bereavement has focused on whether the so-called “bereavement exclusion” in DSM-IV should be eliminated, as some have proposed, in the DSM-5.
Read More
Once Again: Grief Is Not a Disorder, But It May Be Accompanied by Major Depression
January 28th 2012The New York Times ran a front-page story regarding numerous controversies surrounding the DSM-5, most notably, the issue of eliminating the so-called bereavement exclusion in diagnosing a major depressive episode. Here, Dr Pies responds to Dr John Grohol, Psychologist and Editor of the Psychcentral Web site.
Read More
DSM-5 and Diagnostic Inflation: Reply to the DSM-5 Task Force
January 24th 2012My biggest concern regarding DSM-5 is that it will dramatically increase the rates of mental disorder by cheapening the currency of psychiatric diagnosis . . .The whole purpose of field-testing is to identify and correct problems in the preliminary DSM suggestions before they become set in stone as official guides to diagnostic practice.
Read More
Two Fallacies Invalidate the DSM-5 Field Trials
January 10th 2012The designer of the DSM-5 Field Trials has just written a telling commentary in the American Journal of Psychiatry. She makes what I consider to be 2 basic errors that reveal the fundamental worthlessness of these Field Trials and their inability to provide any information that will be useful for DSM-5 decision making.
Read More
California DMH Instructs SVP Evaluators on Proper DSM-IV-TR Diagnosis
January 5th 2012Accurate diagnosis is absolutely crucial in SVP hearings because the potential outcome is so consequential-involuntary incarceration in a psychiatric hospital that may well last a lifetime. In no other clinical or forensic situation does so much ride on the presence or absence of a psychiatric diagnosis.
Read More
Is the Criticism of DSM-5 Misguided?
December 22nd 2011Critics of DSM-5 argue that the expansion of diagnostic criteria may increase the number of “mentally ill” individuals and/or pathologize “normal” behavior, and lead to the possibility that thousands-if not millions-of new patients will be exposed to medications which may cause more harm than good.
Read More
DSM-5: APA Responds to American Counseling Association Concerns
November 24th 2011On November 21, 2011, John Oldham, MD, president of the American Psychiatric Association (APA), wrote a response letter to Don W. Locke, EdD, president of the American Counseling Association, who had some concerns with proposed revisions for DSM-5.
Read More
DSM-5: Petitions, Predictions, and Prescriptions
November 22nd 2011Some months ago, I received a stern admonition from my family doctor. My fasting blood sugar of 99 mg/dL was “right on the border”, he said, and I had better work on bringing it down. “But,” I protested, “when I was in medical school (in the 70s), the normal FBS range went up to 110 mg/dL!” "Well,” he replied a bit huffily, “they changed the criteria!”
Read More
The User’s Revolt Against DSM-5: Will It Work?
November 10th 2011When it comes to DSM-5, experience has proven conclusively that the APA will not attend to the science, evaluate the risks, or listen to reason. A user’s revolt has become the last and only hope for derailing the worst of the DSM-5 suggestions.
Read More
APA Responds Lamely to the Petition to Reform DSM-5
November 8th 2011Last week I challenged the American Psychiatric Association (APA) to end its silence in the face of widespread criticism and finally to mount its belated public defense of DSM-5. These are the 5 questions that cry out for straight answers.
Read More
Why Psychiatrists Should Sign The Petition To Reform DSM-5
November 4th 2011Psychiatrists may be more reluctant than are other mental health clinicians to sign a petition questioning the safety and value of DSM-5. After all, it is the American Psychiatric Association that is sponsoring DSM-5 and there is a natural tendency to want to trust the wisdom of one’s own Association.
Read More
What Would A Useful DSM-5 Look Like? And An Update On The Petition Drive
October 31st 2011The petition to reform DSM-5 continues to gain momentum. In its first full week, more than 2300 people have already expressed their disapproval of the DSM-5 proposals and their desire to see dramatic changes. And the numbers are growing each day.
Read More
Petition Against DSM-5 Gets Off To Racing Start: A Game Changer?
October 27th 2011Just a few days ago, 3 divisions of the American Psychological Association posted a well crafted open letter spelling out the many risks posed by DSM-5 and inviting mental health professionals to sign a petition requesting much needed changes. You can see the letter and (if you agree with it) sign the petition at http://www.ipetitions.com/petition/dsm5/
Read More
Psychologists Petition Against DSM-5: Users Revolt Should Capture APA Attention
October 24th 2011Several divisions of the American Psychological Association have just written an open letter highly critical of DSM-5.They are inviting mental health professionals and mental health organizations to sign a petition addressed to the DSM-5 Task Force of the American Psychiatric Association. You can read the letter and sign up at http://www.ipetitions.com/petition/dsm5/. It is an extremely detailed, thoughtful, and well written statement that deserves your attention and support.
Read More
Some Concerns Regarding Diagnosis
October 22nd 2011The mental health professions are currently awaiting the American Psychiatric Association’s newest version of the Diagnostic and Statistical Manual. The need for a fifth revision underscores the lack of satisfaction within the professions with our diagnostic schema
Read More
Should Temper Tantrums Be Made Into A DSM-5 Diagnosis?
October 13th 2011A recent front page story by Shari Roan in the Los Angeles Times explores the heated controversy over the DSM-5 proposal to include a Disruptive Mood Dysregulation Disorder (DMDD) in DSM-5. I very much oppose the inclusion of this new "disorder."
Read More